Abstract: The present study was designed to explore the mechanism of action of walnut (the seed of Juglans regia) leaf and ridge on hepatic glucose metabolism in diabetic mice. Experimental diabetes was induced by intravenous administration of streptozotocin (60 mg/kg) and confirmed with an increase of blood glucose, 90-100% of the control, 72 hours later. Isolated extracts from walnut leaf and ridges were administered in a single effective dose of 400 mg/kg orally. Firstly, blood glucose was determined every 1 hour until 5 hours post administration of extracts. In the second experiment, the liver was surgically removed, 2 hours post treatment of diabetic animals with extracts, homogenized and used for measurement of key enzymes of glycogenolysis (glycogen phosphorylase, GP) and gluconeogenesis (phosphoenolpyruvate carboxykinase, PEPCK). Treatment by both leaf and ridge extracts decreased blood glucose and liver PEPCK activity and increased blood insulin and liver GP activity. It is concluded that walnut is able to lower blood glucose through inhibition of hepatic gluconeogenesis and secretion of pancreatic insulin.
Introduction
Diabetes mellitus, characterized by hyperglycemia, is the main debilitating metabolic human disease of the century known as one of the top five leading causes of death in the world. Diabetes is characterized by absolute or relative deficiencies in insulin secretion and/ or insulin action associated with chronic hyperglycemia and disturbances of carbohydrate, lipid, and protein metabolism [1] . While most synthetic drugs cause several side and adverse effects, the belief about herballyderived compounds is that they are less toxic than the synthetic ones [2] . Hypoglycemic effects have been proved for some plants containing terpenoids, iridoid glycosides, flavonoids, and other phenolic compounds [3] . In addition, a number of secondary metabolites like flavonoids, phenolic acids, phenylpropanoids, and terpenoids have shown significant antioxidant properties [4-8] and most of products that are rich in antioxidants have been helpful in diabetes [9] [10] [11] .
Glycogenolysis is the catabolism of glycogen which leads to the breakdown of glycogen into glucose and is initiated by glycogen phosphorylase (GP). Gluconeogenesis is the generation of glucose from other non-carbohydrate precursors like pyruvate, lactate, glycerol, and amino acids. Pyruvate carboxylase, phosphoenolpyruvate carboxykinase (PEPCK), fructose 1,6 bis-phosphatase, and glucose-6-phosphatase are key enzymes of this process among which PEPCK is the major target of regulation [12] .
Walnut, the seed of Juglans regia L. (Juglandaceae), is a highly nutritious food that has been used in folk medicine as a remedy for treating of cough, stomachache [13] , and cancer in Asia and Europe [14] . Walnut is rich in oil composed of unsaturated fatty acids, such as linoleic and oleic acid, which are susceptible to oxidation. Although walnut contains the strong antioxidant alpha-tocopherol, its level is lower than that of other nuts like almonds, hazelnuts and peanuts [15] . The walnut also contains antioxidants that inhibit lipid auto-oxidation. Walnut leaves may also constitute a good source of antioxidant, namely phenol, suggesting it could be useful in the prevention of diseases in which free radicals are implicated [16] . The in vivo antioxidative effect of a polyphenol-rich walnut extract in animals with diabetes has been reported [17] [18] [19] .
The present study was designed to explore the mechanism of action of walnut leaf and ridge on hepatic glucose metabolism.
Experimental Procedures

Preparation of extracts
Walnut leaf and ridge were dried and then 300 g of dried leaf and 60 g of dried ridge were extracted by ethanol (80%) in a percolator. The percolator was used to extract all heat-sensitive potent compounds. The extraction was repeated every 3 days until no colorophilic component was detected on TLC. A total of about 23 L of solvent was used in the whole experiment, including 17 L for leaf and more than 6 L for ridge. Dried extract was used in the experiment.
Treatment of animals
Adult male mice, weighing 30-40 g were used in the study. All animals were housed under standard laboratory conditions and allowed free access to normal laboratory chow and water ad libitum. All experiments were performed according to ethical themes of animal welfare approved by Tehran University of Medical Sciences Ethics Committee.
After acclimatization, mice were subjected to a 16-h fast. Acute diabetes was induced in mice with a single intravenous administration of STZ at a dose of 60 mg/kg. Three days after injection of STZ, diabetes was confirmed if a 90-100% increase, in fasting blood glucose level, of controls (70-80 mg/dl) or higher was observed in the STZ-treated animals, meaning a range of 135 mg/dl or higher [20] .
Three groups, each containing five animals, were used as a diabetic control, a diabetic leaf extract-treated group and a ridge extract-treated in the two experiments described below. Effective doses of leaf extract (400 mg/kg) and ridge extract (400 mg/kg) were chosen according to results from a pilot study. Extracts were dissolved in water and administered orally by gavage into diabetic animals. Controls received only water.
The first experiment was done to evaluate blood glucose changes in diabetic control or extract-treated animals. Blood glucose measurement was performed by a glucometer from the mouse tail vein every 1 hour post administration of extracts into diabetic animals for 5 hours to determine the peak level of glucose changes. In the second experiment that was designed to examine hepatic changes, diabetic extract-treated animals were anesthetized 2 hours post administration and the liver was removed by transverse abdominal incision, perfused with cold 0.9% saline and kept frozen at -70°C until homogenized. Blood samples were taken under anesthesia by cardiac puncture for further analyses of insulin concentration.
Hepatic cells PEPCK assay
The isolated liver was cut with scissors and homogenized at 4°C for 2 min with 3 volumes of cold 0.1 M phosphate buffer, pH 7.4, containing a 1 M mixture of KH 2 PO 4 and K 2 HPO 4 . The homogenate was centrifuged for 30 min at 14000 g at 0°C and the supernatant was used for the enzyme activity assay. Enzymatic activity was assayed at 25ºC in the reverse direction (carboxylation of phosphoenolpyruvate to form oxaloacetic acid) in the presence of NADH in a coupled reaction catalyzed by glucose-6-phosphate dehydrogenase as described previously [21] . The activity of PEPCK is expressed as unit per gram of liver protein.
Hepatic cells GP assay
The liver homogenate was centrifuged at 14000 g for 30 min and the supernatant was used for the enzyme activity assay. Liver homogenate was centrifuged at 14000 g for 30 min and the supernatant was used for the enzyme activity assay. Enzymatic activity was assayed in the direction of glycogen breakdown by measuring the reduction of NADP in a coupled reaction catalyzed by glucose-6-phosphate dehydrogenase. GP activity is expressed as unit per gram of liver protein [22] .
Hepatic cells protein assay
The liver homogenate was centrifuged at 14000 g for 30 min and the supernatant was used for determination of protein concentration according to Lowry using bovine plasma albumin as standard [23] .
Insulin assay
Rat ELISA insulin kit (DRG International Inc., USA) was used for determination of serum insulin.
Glucose assay
Glucose levels were measured by a glucometer from Roche Accu-Chek Active, Germany.
Statistical analysis
The results were analyzed for statistical significance by one-way ANOVA and Tukey post hoc multi-comparison tests. All data were expressed as means±SEM of five animals in each group. Differences between groups with P values less than 0.05 was considered statistically significant.
Results
Blood glucose was measured at 0, 1, 2, 3, 4 and 5 h after administration of leaf and ridge extract at doses of 400 mg/kg to diabetic mice. The results showed that walnut decreased blood glucose concentrations by 13.8%, 20.1%, 17.5%, and 21.2% of the control in the leaf extract group and by 11.8%, 18.3%, 13.1%, and 13.1% of the control in the ridge extract group at 1, 2, 3, and 4 h post treatments. The blood glucose concentration at 0 and 5 hours post administration of extracts showed no significant change as compared to controls (Figure 1) .
Administering ridge and leaf extracts at doses of 400 mg/kg increased blood insulin by 14.8% and 22.2% of the control (0.66±0.03 and 0.62±0.03 vs.
0.54±0.02 µg/L; Figure 2).
Ridge and leaf extract at doses of 400 mg/kg diminished PEPCK activity in hepatic cells by 18.27% and 23.5% (13.14±0.65 and 14.12±0.7 vs. 18.5±0.92 U/g liver protein) of the controls (Figure 3) .
Administration of leaf and ridge extracts, at doses of 400 mg/kg, increased GP activity in hepatic cells by 25.8% and 15. 
Discussion
The goal of the present study was to assess the hepatic mechanism of the antidiabetic effect of walnut leaf and ridge extracts in STZ-induced diabetic mice. Our results confirm that both leaf and ridge extracts from walnut have adequate potential in protection against STZinduced diabetes in mice by increasing blood insulin and inhibition of hepatic gluconeogenesis.
Considering the known antioxidant potential of walnut and evidence for the role of reactive free radicals and disturbed antioxidant status in the pathogenesis of diabetes and its complications [1, [24] [25] [26] [27] , the observed hepatic changes might the attributed to the antioxidants in walnut. Walnut leaf and ridge extracts are known to contain high amounts of strong antioxidant components like vitamin C, vitamin E, beta-carotene, lipoic acid, quercetin, naphtoquinones, flavonoids, gallic acid, polyphenols, linoleic and linolenic acids, tannins, and folates that have shown very beneficial anti-diabetic effects in in vitro or in vivo models and in humans [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] . Thus, one can speculate that the observed favorable changes in insulin secretion and hepatic gluconeogenesis reported by us are also related to the anti-oxidant effect of walnut, but this hypothesis requires further experimental support. The observed stimulation of glycogen phosphorylase by walnut extracts may also support the antioxidant mechanisms in the liver. Glycogenolysis generates the substrate for the glucose-6-phosphate dehydrogenase which catalyzes the initial step of the pentose phosphate pathway with a well defined function in the reduction of NADP to NADPH, a mediator for reduction of oxidized glutathione to the reduced state (GSH). GSH detoxifies the oxidants hydrogen peroxide and organic peroxides. Thus, if glucose is the first source of reducing equivalents which are involved in the recycling of oxidized cellular antioxidants [11] this means that homeostasis of hepatic glucose is tightly coupled to the oxidant/antioxidant status [43] [44] [45] . Thus, if hepatic glycogenolysis has been stimulated by walnut, it may provide more glucose to enter the pentose phosphate pathway.
Collectively, the present data confirm the antidiabetic mechanism of walnut. Mixing of both leaf and ridge deserves attention as a tool to reach synergistic or additive antidiabetic effects in future pharmacological agents based on walnut-derived active ingredients.
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